No Result

View All Result

No products in the cart.

2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑

Home StudyGraphics

#VisualAbstract PEITHO-2 shows that switching from heparin to dabigatran early in patients with acute intermediate-risk pulmonary embolism is safe and effective

byKathleen Lau

August 27, 2021

in StudyGraphics

#VisualAbstract PEITHO-2 shows that switching from heparin to dabigatran early in patients with acute intermediate-risk pulmonary embolism is safe and effective

Intracerebral hemorrhage risk factors and risk factor burden may differ across racial groups

RelatedReports

Hematology

N-methylaniline exposure identified as likely cause of methemoglobinemia during maritime migration

September 13, 2026

Combined lenalidomide and rituximab dose escalation found to be safe for CLL

All Specialties

Venetoclax (Venclyxto) expands treatment options as chronic lymphocytic leukemia care moves further from chemotherapy

June 8, 2026

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization

Cardiology

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

April 9, 2026

2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]

Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026

Postextubation administration of high-flow oxygen leads to reduced reintubation and respiratory failure

VieScope as a comparable alternative to Macintosh and Glidescope laryngoscopy for securing difficult airways

Reduced gestational weight gain with lifestyle intervention

Health wearable devices effectively promote bodyweight in overweight/obese individuals

Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source

Continuous electrocardiogram monitoring following discharge detects atrial fibrillation in postoperative cardiac patients

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract PEITHO-2 shows that switching from heparin to dabigatran early in patients with acute intermediate-risk pulmonary embolism is safe and effective

N-methylaniline exposure identified as likely cause of methemoglobinemia during maritime migration

Venetoclax (Venclyxto) expands treatment options as chronic lymphocytic leukemia care moves further from chemotherapy

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

Intracerebral hemorrhage risk factors and risk factor burden may differ across racial groups

VieScope as a comparable alternative to Macintosh and Glidescope laryngoscopy for securing difficult airways

RelatedReports

N-methylaniline exposure identified as likely cause of methemoglobinemia during maritime migration

Venetoclax (Venclyxto) expands treatment options as chronic lymphocytic leukemia care moves further from chemotherapy

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

VieScope as a comparable alternative to Macintosh and Glidescope laryngoscopy for securing difficult airways

Health wearable devices effectively promote bodyweight in overweight/obese individuals

Continuous electrocardiogram monitoring following discharge detects atrial fibrillation in postoperative cardiac patients

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits

#VisualAbstract PEITHO-2 shows that switching from heparin to dabigatran early in patients with acute intermediate-risk pulmonary embolism is safe and effective

RELATED REPORTS

Intracerebral hemorrhage risk factors and risk factor burden may differ across racial groups

VieScope as a comparable alternative to Macintosh and Glidescope laryngoscopy for securing difficult airways

RelatedReports

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits